Luca Arecco, Clinical Research Fellow at ESMO, posted on X about recent paper he and colleagues co-authored:
“Published in Journal of the National Cancer Institute (JNCI) our analysis assessing the prognosis of patients considered at high risk of recurrence according to monarchE and NATALEE trials inclusion criteria!”
“Prognostic implications of risk definitions from the monarchE and NATALEE trials.”
Authors: Luca Arecco, Eva Blondeaux, Marco Bruzzone, Grazia Arpino, Carmine De Angelis, Michelino De Laurentiis, Roberta Caputo, Alessandra Fabi, Valeria Sanna, Stefania Gori, Fabio Puglisi, Luca Boni, Simone Nardin, Irene Giannubilo, Marta Perachino, Roberto Borea, Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini, Lucia Del Mastro
